{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,14]],"date-time":"2026-11-14T00:15:34Z","timestamp":1794615334662,"version":"4.9.1"},"reference-count":67,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2021,12,14]],"date-time":"2021-12-14T00:00:00Z","timestamp":1639440000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2021,12,14]],"date-time":"2021-12-14T00:00:00Z","timestamp":1639440000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["92057122"],"award-info":[{"award-number":["92057122"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["81874323"],"award-info":[{"award-number":["81874323"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Nat Commun"],"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:p>Several members of the FGF family have been identified as potential regulators of glucose homeostasis. We previously reported that a low threshold of FGF-induced FGF receptor 1c (FGFR1c) dimerization and activity is sufficient to evoke a glucose lowering activity. We therefore reasoned that ligand identity may not matter, and that besides paracrine FGF1 and endocrine FGF21, other cognate paracrine FGFs of FGFR1c might possess such activity. Indeed, via a side-by-side testing of multiple cognate FGFs of FGFR1c in diabetic mice we identified the paracrine FGF4 as a potent anti-hyperglycemic FGF. Importantly, we found that like FGF1, the paracrine FGF4 is also more efficacious than endocrine FGF21 in lowering blood glucose. We show that paracrine FGF4 and FGF1 exert their superior glycemic control by targeting skeletal muscle, which expresses copious FGFR1c but lacks \u03b2-klotho (KLB), an obligatory FGF21 co-receptor. Mechanistically, both FGF4 and FGF1 upregulate GLUT4 cell surface abundance in skeletal muscle in an AMPK\u03b1-dependent but insulin-independent manner. Chronic treatment with rFGF4 improves insulin resistance and suppresses adipose macrophage infiltration and inflammation. Notably, unlike FGF1 (a pan-FGFR ligand), FGF4, which has more restricted FGFR1c binding specificity, has no apparent effect on food intake. The potent anti-hyperglycemic and anti-inflammatory properties of FGF4 testify to its promising potential for use in the treatment of T2D and related metabolic disorders.<\/jats:p>","DOI":"10.1038\/s41467-021-27584-y","type":"journal-article","created":{"date-parts":[[2021,12,14]],"date-time":"2021-12-14T06:03:55Z","timestamp":1639461835000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":68,"title":["Paracrine FGFs target skeletal muscle to exert potent anti-hyperglycemic effects"],"prefix":"10.1038","volume":"12","author":[{"given":"Lei","family":"Ying","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Luyao","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kaiwen","family":"Guo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yushu","family":"Hou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Na","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shuyi","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xingfeng","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qijin","family":"Zhao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jie","family":"Zhou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Longwei","family":"Zhao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jianlou","family":"Niu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chuchu","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lintao","family":"Song","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shaocong","family":"Hou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lijuan","family":"Kong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaokun","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0275-0783","authenticated-orcid":false,"given":"Jun","family":"Ren","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0679-270X","authenticated-orcid":false,"given":"Pingping","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2434-9437","authenticated-orcid":false,"given":"Moosa","family":"Mohammadi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8269-6731","authenticated-orcid":false,"given":"Zhifeng","family":"Huang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2021,12,14]]},"reference":[{"key":"27584_CR1","doi-asserted-by":"crossref","first-page":"205","DOI":"10.1016\/j.cytogfr.2005.02.003","volume":"16","author":"DM Ornitz","year":"2005","unstructured":"Ornitz, D. M. FGF signaling in the developing endochondral skeleton. Cytokine Growth Factor Rev. 16, 205\u2013213 (2005).","journal-title":"Cytokine Growth Factor Rev."},{"key":"27584_CR2","doi-asserted-by":"crossref","first-page":"235","DOI":"10.1038\/nrd2792","volume":"8","author":"A Beenken","year":"2009","unstructured":"Beenken, A. & Mohammadi, M. The FGF family: biology, pathophysiology and therapy. Nat. Rev. Drug Disco. 8, 235\u2013253 (2009).","journal-title":"Nat. Rev. Drug Disco."},{"key":"27584_CR3","doi-asserted-by":"crossref","first-page":"1627","DOI":"10.1172\/JCI23606","volume":"115","author":"A Kharitonenkov","year":"2005","unstructured":"Kharitonenkov, A. et al. FGF-21 as a novel metabolic regulator. J. Clin. Invest. 115, 1627\u20131635 (2005).","journal-title":"J. Clin. Invest."},{"key":"27584_CR4","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1038\/nrd.2015.9","volume":"15","author":"C Degirolamo","year":"2016","unstructured":"Degirolamo, C., Sabba, C. & Moschetta, A. Therapeutic potential of the endocrine fibroblast growth factors FGF19, FGF21 and FGF23. Nat. Rev. Drug Discov. 15, 51\u201369 (2016).","journal-title":"Nat. Rev. Drug Discov."},{"key":"27584_CR5","doi-asserted-by":"crossref","first-page":"436","DOI":"10.1038\/nature13540","volume":"513","author":"JM Suh","year":"2014","unstructured":"Suh, J. M. et al. Endocrinization of FGF1 produces a neomorphic and potent insulin sensitizer. Nature 513, 436 (2014).","journal-title":"Nature"},{"key":"27584_CR6","doi-asserted-by":"crossref","first-page":"599","DOI":"10.1038\/nrendo.2017.78","volume":"13","author":"E Gasser","year":"2017","unstructured":"Gasser, E., Moutos, C. P., Downes, M. & Evans, R. M. FGF1 - a new weapon to control type 2 diabetes mellitus. Nat. Rev. Endocrinol. 13, 599\u2013609 (2017).","journal-title":"Nat. Rev. Endocrinol."},{"key":"27584_CR7","doi-asserted-by":"crossref","first-page":"565","DOI":"10.1517\/14740338.2012.691963","volume":"11","author":"J Kung","year":"2012","unstructured":"Kung, J. & Henry, R. R. Thiazolidinedione safety. Expert Opin. Drug Saf. 11, 565\u2013579 (2012).","journal-title":"Expert Opin. Drug Saf."},{"key":"27584_CR8","doi-asserted-by":"crossref","first-page":"743","DOI":"10.1016\/S1097-2765(00)00073-3","volume":"6","author":"J Schlessinger","year":"2000","unstructured":"Schlessinger, J. et al. Crystal structure of a ternary FGF-FGFR-heparin complex reveals a dual role for heparin in FGFR binding and dimerization. Mol. Cell 6, 743\u2013750 (2000).","journal-title":"Mol. Cell"},{"key":"27584_CR9","doi-asserted-by":"crossref","first-page":"166","DOI":"10.1038\/nrm3528","volume":"14","author":"R Goetz","year":"2013","unstructured":"Goetz, R. & Mohammadi, M. Exploring mechanisms of FGF signalling through the lens of structural biology. Nat. Rev. Mol. Cell Bio. 14, 166\u2013180 (2013).","journal-title":"Nat. Rev. Mol. Cell Bio."},{"key":"27584_CR10","doi-asserted-by":"crossref","first-page":"26687","DOI":"10.1074\/jbc.M704165200","volume":"282","author":"H Kurosu","year":"2007","unstructured":"Kurosu, H. et al. Tissue-specific expression of betaKlotho and fibroblast growth factor (FGF) receptor isoforms determines metabolic activity of FGF19 and FGF21. J. Biol. Chem. 282, 26687\u201326695 (2007).","journal-title":"J. Biol. Chem."},{"key":"27584_CR11","doi-asserted-by":"crossref","first-page":"547","DOI":"10.1038\/s41584-020-0469-2","volume":"16","author":"Y Xie","year":"2020","unstructured":"Xie, Y., Zinkle, A., Chen, L. & Mohammadi, M. Fibroblast growth factor signalling in osteoarthritis and cartilage repair. Nat. Rev. Rheumatol. 16, 547\u2013564 (2020).","journal-title":"Nat. Rev. Rheumatol."},{"key":"27584_CR12","doi-asserted-by":"crossref","first-page":"233","DOI":"10.1016\/j.cytogfr.2005.01.007","volume":"16","author":"L Dailey","year":"2005","unstructured":"Dailey, L., Ambrosetti, D., Mansukhani, A. & Basilico, C. Mechanisms underlying differential responses to FGF signaling. Cytokine Growth F. R. 16, 233\u2013247 (2005).","journal-title":"Cytokine Growth F. R."},{"key":"27584_CR13","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1016\/j.cytogfr.2005.01.001","volume":"16","author":"VP Eswarakumar","year":"2005","unstructured":"Eswarakumar, V. P., Lax, I. & Schlessinger, J. Cellular signaling by fibroblast growth factor receptors. Cytokine Growth F. R. 16, 139\u2013149 (2005).","journal-title":"Cytokine Growth F. R."},{"key":"27584_CR14","doi-asserted-by":"crossref","first-page":"693","DOI":"10.1016\/S0092-8674(00)80252-4","volume":"89","author":"H Kouhara","year":"1997","unstructured":"Kouhara, H. et al. A lipid-anchored Grb2-binding protein that links FGF-receptor activation to the Ras\/MAPK signaling pathway. Cell 89, 693\u2013702 (1997).","journal-title":"Cell"},{"key":"27584_CR15","doi-asserted-by":"crossref","first-page":"12553","DOI":"10.1073\/pnas.1006962107","volume":"107","author":"MD Chau","year":"2010","unstructured":"Chau, M. D., Gao, J., Yang, Q., Wu, Z. & Gromada, J. Fibroblast growth factor 21 regulates energy metabolism by activating the AMPK-SIRT1-PGC-1alpha pathway. Proc. Natl Acad. Sci. USA 107, 12553\u201312558 (2010).","journal-title":"Proc. Natl Acad. Sci. USA"},{"key":"27584_CR16","doi-asserted-by":"crossref","first-page":"1717","DOI":"10.1016\/j.celrep.2017.06.063","volume":"20","author":"Z Huang","year":"2017","unstructured":"Huang, Z. et al. Uncoupling the mitogenic and metabolic functions of FGF1 by tuning FGF1-FGF receptor dimer stability. Cell Rep. 20, 1717\u20131728 (2017).","journal-title":"Cell Rep."},{"key":"27584_CR17","doi-asserted-by":"publisher","unstructured":"Zinkle, A. & Mohammadi, M. A threshold model for receptor tyrosine kinase signaling specificity and cell fate determination. F1000Res 7, https:\/\/doi.org\/10.12688\/f1000research.14143.1 (2018).","DOI":"10.12688\/f1000research.14143.1"},{"key":"27584_CR18","doi-asserted-by":"crossref","first-page":"15292","DOI":"10.1074\/jbc.271.25.15292","volume":"271","author":"DM Ornitz","year":"1996","unstructured":"Ornitz, D. M. et al. Receptor specificity of the fibroblast growth factor family. J. Biol. Chem. 271, 15292\u201315297 (1996).","journal-title":"J. Biol. Chem."},{"key":"27584_CR19","doi-asserted-by":"crossref","first-page":"15694","DOI":"10.1074\/jbc.M601252200","volume":"281","author":"X Zhang","year":"2006","unstructured":"Zhang, X. et al. Receptor specificity of the fibroblast growth factor family. The complete mammalian FGF family. J. Biol. Chem. 281, 15694\u201315700 (2006).","journal-title":"J. Biol. Chem."},{"key":"27584_CR20","doi-asserted-by":"crossref","first-page":"250","DOI":"10.2337\/db08-0392","volume":"58","author":"J Xu","year":"2009","unstructured":"Xu, J. et al. Fibroblast growth factor 21 reverses hepatic steatosis, increases energy expenditure, and improves insulin sensitivity in diet-induced obese mice. Diabetes 58, 250\u2013259 (2009).","journal-title":"Diabetes"},{"key":"27584_CR21","doi-asserted-by":"crossref","first-page":"6018","DOI":"10.1210\/en.2008-0816","volume":"149","author":"T Coskun","year":"2008","unstructured":"Coskun, T. et al. Fibroblast growth factor 21 corrects obesity in mice. Endocrinology 149, 6018\u20136027 (2008).","journal-title":"Endocrinology"},{"key":"27584_CR22","doi-asserted-by":"crossref","first-page":"315","DOI":"10.1002\/iub.315","volume":"62","author":"R Augustin","year":"2010","unstructured":"Augustin, R. The protein family of glucose transport facilitators: It\u2019s not only about glucose after all. IUBMB Life 62, 315\u2013333 (2010).","journal-title":"IUBMB Life"},{"key":"27584_CR23","doi-asserted-by":"crossref","first-page":"924","DOI":"10.1038\/78693","volume":"6","author":"A Zisman","year":"2000","unstructured":"Zisman, A. et al. Targeted disruption of the glucose transporter 4 selectively in muscle causes insulin resistance and glucose intolerance. Nat. Med. 6, 924\u2013928 (2000).","journal-title":"Nat. Med."},{"key":"27584_CR24","doi-asserted-by":"crossref","first-page":"251","DOI":"10.1038\/nrm3311","volume":"13","author":"DG Hardie","year":"2012","unstructured":"Hardie, D. G., Ross, F. A. & Hawley, S. A. AMPK: a nutrient and energy sensor that maintains energy homeostasis. Nat. Rev. Mol. Cell Biol. 13, 251\u2013262 (2012).","journal-title":"Nat. Rev. Mol. Cell Biol."},{"key":"27584_CR25","doi-asserted-by":"crossref","first-page":"237","DOI":"10.1016\/j.cmet.2007.03.006","volume":"5","author":"S Huang","year":"2007","unstructured":"Huang, S. & Czech, M. P. The GLUT4 glucose transporter. Cell Metab. 5, 237\u2013252 (2007).","journal-title":"Cell Metab."},{"key":"27584_CR26","doi-asserted-by":"crossref","first-page":"104","DOI":"10.1016\/j.cmet.2011.05.009","volume":"14","author":"WT Wong","year":"2011","unstructured":"Wong, W. T. et al. Adiponectin is required for PPARgamma-mediated improvement of endothelial function in diabetic mice. Cell Metab. 14, 104\u2013115 (2011).","journal-title":"Cell Metab."},{"key":"27584_CR27","doi-asserted-by":"crossref","first-page":"2050","DOI":"10.1210\/me.2010-0142","volume":"24","author":"K Fon Tacer","year":"2010","unstructured":"Fon Tacer, K. et al. Research resource: comprehensive expression atlas of the fibroblast growth factor system in adult mouse. Mol. Endocrinol. 24, 2050\u20132064 (2010).","journal-title":"Mol. Endocrinol."},{"key":"27584_CR28","first-page":"569","volume":"286","author":"RL Panek","year":"1998","unstructured":"Panek, R. L. et al. In vitro biological characterization and antiangiogenic effects of PD 166866, a selective inhibitor of the FGF-1 receptor tyrosine kinase. J. Pharm. Exp. Ther. 286, 569\u2013577 (1998).","journal-title":"J. Pharm. Exp. Ther."},{"key":"27584_CR29","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1016\/j.tibs.2006.02.007","volume":"31","author":"RT Watson","year":"2006","unstructured":"Watson, R. T. & Pessin, J. E. Bridging the GAP between insulin signaling and GLUT4 translocation. Trends Biochem. Sci. 31, 215\u2013222 (2006).","journal-title":"Trends Biochem. Sci."},{"key":"27584_CR30","doi-asserted-by":"crossref","first-page":"98","DOI":"10.1016\/j.molcel.2015.11.010","volume":"61","author":"Z Huang","year":"2016","unstructured":"Huang, Z. et al. Two FGF receptor kinase molecules act in concert to recruit and transphosphorylate phospholipase Cgamma. Mol. Cell 61, 98\u2013110 (2016).","journal-title":"Mol. Cell"},{"key":"27584_CR31","doi-asserted-by":"crossref","first-page":"11650","DOI":"10.1074\/jbc.273.19.11650","volume":"273","author":"MV Ellis","year":"1998","unstructured":"Ellis, M. V. et al. Catalytic domain of phosphoinositide-specific phospholipase C (PLC). Mutational analysis of residues within the active site and hydrophobic ridge of plcdelta1. J. Biol. Chem. 273, 11650\u201311659 (1998).","journal-title":"J. Biol. Chem."},{"key":"27584_CR32","doi-asserted-by":"crossref","first-page":"197","DOI":"10.1038\/35004606","volume":"404","author":"J Schlossmann","year":"2000","unstructured":"Schlossmann, J. et al. Regulation of intracellular calcium by a signalling complex of IRAG, IP3 receptor and cGMP kinase Ibeta. Nature 404, 197\u2013201 (2000).","journal-title":"Nature"},{"key":"27584_CR33","doi-asserted-by":"crossref","first-page":"377","DOI":"10.1016\/j.cmet.2008.02.011","volume":"7","author":"KA Anderson","year":"2008","unstructured":"Anderson, K. A. et al. Hypothalamic CaMKK2 contributes to the regulation of energy balance. Cell Metab. 7, 377\u2013388 (2008).","journal-title":"Cell Metab."},{"key":"27584_CR34","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1016\/j.cmet.2005.05.009","volume":"2","author":"SA Hawley","year":"2005","unstructured":"Hawley, S. A. et al. Calmodulin-dependent protein kinase kinase-beta is an alternative upstream kinase for AMP-activated protein kinase. Cell Metab. 2, 9\u201319 (2005).","journal-title":"Cell Metab."},{"key":"27584_CR35","doi-asserted-by":"publisher","DOI":"10.1016\/j.cmet.2019.05.018","author":"M Li","year":"2019","unstructured":"Li, M. et al. Transient receptor potential V channels are essential for glucose sensing by aldolase and AMPK. Cell Metab. https:\/\/doi.org\/10.1016\/j.cmet.2019.05.018 (2019).","journal-title":"Cell Metab."},{"key":"27584_CR36","doi-asserted-by":"crossref","first-page":"15813","DOI":"10.1074\/jbc.M201075200","volume":"277","author":"H Tokumitsu","year":"2002","unstructured":"Tokumitsu, H. et al. STO-609, a specific inhibitor of the Ca(2+)\/calmodulin-dependent protein kinase kinase. J. Biol. Chem. 277, 15813\u201315818 (2002).","journal-title":"J. Biol. Chem."},{"key":"27584_CR37","doi-asserted-by":"crossref","first-page":"265","DOI":"10.1002\/dvdy.21699","volume":"238","author":"N Kosaka","year":"2009","unstructured":"Kosaka, N., Sakamoto, H., Terada, M. & Ochiya, T. Pleiotropic function of FGF-4: its role in development and stem cells. Dev. Dyn. 238, 265\u2013276 (2009).","journal-title":"Dev. Dyn."},{"key":"27584_CR38","doi-asserted-by":"crossref","first-page":"14158","DOI":"10.1073\/pnas.1009427107","volume":"107","author":"X Wu","year":"2010","unstructured":"Wu, X. et al. Separating mitogenic and metabolic activities of fibroblast growth factor 19 (FGF19). Proc. Natl Acad. Sci. USA 107, 14158\u201314163 (2010).","journal-title":"Proc. Natl Acad. Sci. USA"},{"key":"27584_CR39","doi-asserted-by":"crossref","first-page":"29025","DOI":"10.1073\/pnas.2010984117","volume":"117","author":"J Niu","year":"2020","unstructured":"Niu, J. et al. Curtailing FGF19\u2019s mitogenicity by suppressing its receptor dimerization ability. Proc. Natl Acad. Sci. USA 117, 29025\u201329034 (2020).","journal-title":"Proc. Natl Acad. Sci. USA"},{"key":"27584_CR40","doi-asserted-by":"crossref","first-page":"1147","DOI":"10.1016\/j.cmet.2017.04.010","volume":"25","author":"EC Cokorinos","year":"2017","unstructured":"Cokorinos, E. C. et al. Activation of skeletal muscle AMPK promotes glucose disposal and glucose lowering in non-human primates and mice. Cell Metab. 25, 1147\u20131159 e1110 (2017).","journal-title":"Cell Metab."},{"key":"27584_CR41","doi-asserted-by":"crossref","first-page":"1796","DOI":"10.1172\/JCI200319246","volume":"112","author":"SP Weisberg","year":"2003","unstructured":"Weisberg, S. P. et al. Obesity is associated with macrophage accumulation in adipose tissue. J. Clin. Invest 112, 1796\u20131808 (2003).","journal-title":"J. Clin. Invest"},{"key":"27584_CR42","doi-asserted-by":"crossref","first-page":"973","DOI":"10.1016\/j.cell.2016.10.025","volume":"167","author":"P Li","year":"2016","unstructured":"Li, P. et al. Hematopoietic-derived galectin-3 causes cellular and systemic insulin resistance. Cell 167, 973\u2013984 e912 (2016).","journal-title":"Cell"},{"key":"27584_CR43","doi-asserted-by":"crossref","first-page":"15333","DOI":"10.1074\/jbc.M110.100263","volume":"285","author":"P Li","year":"2010","unstructured":"Li, P. et al. Functional heterogeneity of CD11c-positive adipose tissue macrophages in diet-induced obese mice. J. Biol. Chem. 285, 15333\u201315345 (2010).","journal-title":"J. Biol. Chem."},{"key":"27584_CR44","doi-asserted-by":"crossref","first-page":"175","DOI":"10.1172\/JCI29881","volume":"117","author":"CN Lumeng","year":"2007","unstructured":"Lumeng, C. N., Bodzin, J. L. & Saltiel, A. R. Obesity induces a phenotypic switch in adipose tissue macrophage polarization. J. Clin. Invest 117, 175\u2013184 (2007).","journal-title":"J. Clin. Invest"},{"key":"27584_CR45","doi-asserted-by":"crossref","first-page":"687","DOI":"10.1248\/bpb.b14-00276","volume":"38","author":"Y Masuda","year":"2015","unstructured":"Masuda, Y. et al. Expression of Fgf23 in activated dendritic cells and macrophages in response to immunological stimuli in mice. Biol. Pharm. Bull. 38, 687\u2013693 (2015).","journal-title":"Biol. Pharm. Bull."},{"key":"27584_CR46","doi-asserted-by":"crossref","first-page":"346","DOI":"10.1038\/nature11862","volume":"493","author":"LA O\u2019Neill","year":"2013","unstructured":"O\u2019Neill, L. A. & Hardie, D. G. Metabolism of inflammation limited by AMPK and pseudo-starvation. Nature 493, 346\u2013355 (2013).","journal-title":"Nature"},{"key":"27584_CR47","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1093\/jb\/mvq121","volume":"149","author":"N Itoh","year":"2011","unstructured":"Itoh, N. & Ornitz, D. M. Fibroblast growth factors: from molecular evolution to roles in development, metabolism and disease. J. Biochem. 149, 121\u2013130 (2011).","journal-title":"J. Biochem."},{"key":"27584_CR48","doi-asserted-by":"crossref","first-page":"272","DOI":"10.1017\/S0029665118002665","volume":"78","author":"M Travaglio","year":"2019","unstructured":"Travaglio, M. & Ebling, F. J. P. Role of hypothalamic tanycytes in nutrient sensing and energy balance. Proc. Nutr. Soc. 78, 272\u2013278 (2019).","journal-title":"Proc. Nutr. Soc."},{"key":"27584_CR49","doi-asserted-by":"crossref","first-page":"6170","DOI":"10.1523\/JNEUROSCI.2437-12.2013","volume":"33","author":"N Haan","year":"2013","unstructured":"Haan, N. et al. Fgf10-expressing tanycytes add new neurons to the appetite\/energy-balance regulating centers of the postnatal and adult hypothalamus. J. Neurosci. 33, 6170\u20136180 (2013).","journal-title":"J. Neurosci."},{"key":"27584_CR50","doi-asserted-by":"crossref","first-page":"223","DOI":"10.1146\/annurev-physiol-021115-105339","volume":"78","author":"FM Fisher","year":"2016","unstructured":"Fisher, F. M. & Maratos-Flier, E. Understanding the physiology of FGF21. Annu Rev. Physiol. 78, 223\u2013241 (2016).","journal-title":"Annu Rev. Physiol."},{"key":"27584_CR51","doi-asserted-by":"crossref","first-page":"799","DOI":"10.1038\/414799a","volume":"414","author":"AR Saltiel","year":"2001","unstructured":"Saltiel, A. R. & Kahn, C. R. Insulin signalling and the regulation of glucose and lipid metabolism. Nature 414, 799\u2013806 (2001).","journal-title":"Nature"},{"key":"27584_CR52","doi-asserted-by":"crossref","first-page":"228","DOI":"10.2337\/diacare.13.3.228","volume":"13","author":"A Klip","year":"1990","unstructured":"Klip, A. & Paquet, M. R. Glucose transport and glucose transporters in muscle and their metabolic regulation. Diabetes Care 13, 228\u2013243 (1990).","journal-title":"Diabetes Care"},{"key":"27584_CR53","doi-asserted-by":"crossref","first-page":"2911","DOI":"10.2337\/db16-0305","volume":"65","author":"JM Gurley","year":"2016","unstructured":"Gurley, J. M., Griesel, B. A. & Olson, A. L. Increased skeletal muscle GLUT4 expression in obese mice after voluntary wheel running exercise is posttranscriptional. Diabetes 65, 2911\u20132919 (2016).","journal-title":"Diabetes"},{"key":"27584_CR54","doi-asserted-by":"crossref","DOI":"10.1186\/s12967-015-0412-5","volume":"13","author":"BR Sharma","year":"2015","unstructured":"Sharma, B. R., Kim, H. J. & Rhyu, D. Y. Caulerpa lentillifera extract ameliorates insulin resistance and regulates glucose metabolism in C57BL\/KsJ-db\/db mice via PI3K\/AKT signaling pathway in myocytes. J. Transl. Med. 13, 62 (2015).","journal-title":"J. Transl. Med."},{"key":"27584_CR55","doi-asserted-by":"crossref","first-page":"785","DOI":"10.1530\/eje.0.1450785","volume":"145","author":"T Miura","year":"2001","unstructured":"Miura, T. et al. Impairment of insulin-stimulated GLUT4 translocation in skeletal muscle and adipose tissue in the Tsumura Suzuki obese diabetic mouse: a new genetic animal model of type 2 diabetes. Eur. J. Endocrinol. 145, 785\u2013790 (2001).","journal-title":"Eur. J. Endocrinol."},{"key":"27584_CR56","doi-asserted-by":"crossref","first-page":"1568","DOI":"10.1172\/JCI116025","volume":"90","author":"PA King","year":"1992","unstructured":"King, P. A., Horton, E. D., Hirshman, M. F. & Horton, E. S. Insulin resistance in obese Zucker rat (fa\/fa) skeletal muscle is associated with a failure of glucose transporter translocation. J. Clin. Invest. 90, 1568\u20131575 (1992).","journal-title":"J. Clin. Invest."},{"key":"27584_CR57","doi-asserted-by":"crossref","first-page":"429","DOI":"10.1172\/JCI117673","volume":"95","author":"JM Ren","year":"1995","unstructured":"Ren, J. M. et al. Overexpression of Glut4 protein in muscle increases basal and insulin-stimulated whole body glucose disposal in conscious mice. J. Clin. Invest. 95, 429\u2013432 (1995).","journal-title":"J. Clin. Invest."},{"key":"27584_CR58","doi-asserted-by":"crossref","first-page":"449","DOI":"10.1042\/BJ20071114","volume":"409","author":"S Chen","year":"2008","unstructured":"Chen, S. et al. Complementary regulation of TBC1D1 and AS160 by growth factors, insulin and AMPK activators. Biochem. J. 409, 449\u2013459 (2008).","journal-title":"Biochem. J."},{"key":"27584_CR59","doi-asserted-by":"crossref","first-page":"993","DOI":"10.1152\/physrev.00038.2012","volume":"93","author":"EA Richter","year":"2013","unstructured":"Richter, E. A. & Hargreaves, M. Exercise, GLUT4, and skeletal muscle glucose uptake. Physiol. Rev. 93, 993\u20131017 (2013).","journal-title":"Physiol. Rev."},{"key":"27584_CR60","doi-asserted-by":"crossref","first-page":"261","DOI":"10.1042\/BJ20082055","volume":"418","author":"EA Richter","year":"2009","unstructured":"Richter, E. A. & Ruderman, N. B. AMPK and the biochemistry of exercise: implications for human health and disease. Biochem. J. 418, 261\u2013275 (2009).","journal-title":"Biochem. J."},{"key":"27584_CR61","doi-asserted-by":"crossref","first-page":"E331","DOI":"10.1152\/ajpendo.00243.2006","volume":"292","author":"SB Jorgensen","year":"2007","unstructured":"Jorgensen, S. B. et al. Role of AMPKalpha2 in basal, training-, and AICAR-induced GLUT4, hexokinase II, and mitochondrial protein expression in mouse muscle. Am. J. Physiol. Endocrinol. Metab. 292, E331\u2013E339 (2007).","journal-title":"Am. J. Physiol. Endocrinol. Metab."},{"key":"27584_CR62","doi-asserted-by":"crossref","first-page":"860","DOI":"10.2337\/db07-0843","volume":"57","author":"SL McGee","year":"2008","unstructured":"McGee, S. L. et al. AMP-activated protein kinase regulates GLUT4 transcription by phosphorylating histone deacetylase 5. Diabetes 57, 860\u2013867 (2008).","journal-title":"Diabetes"},{"key":"27584_CR63","doi-asserted-by":"crossref","first-page":"507","DOI":"10.1126\/science.aah5582","volume":"357","author":"RW Myers","year":"2017","unstructured":"Myers, R. W. et al. Systemic pan-AMPK activator MK-8722 improves glucose homeostasis but induces cardiac hypertrophy. Science 357, 507\u2013511 (2017).","journal-title":"Science"},{"key":"27584_CR64","doi-asserted-by":"crossref","first-page":"363","DOI":"10.1194\/jlr.M038786","volume":"55","author":"J Dong","year":"2014","unstructured":"Dong, J. et al. Quercetin reduces obesity-associated ATM infiltration and inflammation in mice: a mechanism including AMPKalpha1\/SIRT1. J. Lipid Res. 55, 363\u2013374 (2014).","journal-title":"J. Lipid Res."},{"key":"27584_CR65","first-page":"4","volume":"17","author":"JP Bastard","year":"2006","unstructured":"Bastard, J. P. et al. Recent advances in the relationship between obesity, inflammation, and insulin resistance. Eur. Cytokine Netw. 17, 4\u201312 (2006).","journal-title":"Eur. Cytokine Netw."},{"key":"27584_CR66","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1172\/JCI16567","volume":"111","author":"B Viollet","year":"2003","unstructured":"Viollet, B. et al. The AMP-activated protein kinase alpha2 catalytic subunit controls whole-body insulin sensitivity. J. Clin. Invest. 111, 91\u201398 (2003).","journal-title":"J. Clin. Invest."},{"key":"27584_CR67","first-page":"pdb prot5080","volume":"2008","author":"J Weischenfeldt","year":"2008","unstructured":"Weischenfeldt, J. & Porse, B. Bone marrow-derived macrophages (BMM): isolation and applications. CSH Protoc. 2008, pdb prot5080 (2008).","journal-title":"CSH Protoc."}],"container-title":["Nature Communications"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41467-021-27584-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41467-021-27584-y","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41467-021-27584-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,11,13]],"date-time":"2023-11-13T21:42:28Z","timestamp":1699911748000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41467-021-27584-y"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,12,14]]},"references-count":67,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2021,12]]}},"alternative-id":["27584"],"URL":"https:\/\/doi.org\/10.1038\/s41467-021-27584-y","relation":{},"ISSN":["2041-1723"],"issn-type":[{"value":"2041-1723","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,12,14]]},"assertion":[{"value":"3 January 2021","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"29 November 2021","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"14 December 2021","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"7256"}}